Cargando…
Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in Non-diabetic patients
BACKGROUND: High-concentration-capsaicin-patches (Qutenza®) have been put on the market as a treatment for peripheral neuropathic pain. A minimum infrastructure and a determinate skill set for its application are required. Our aim was to assess the feasibility of treatment with high-concentration-ca...
Autores principales: | Giménez-Milà, Marc, Videla, Sebastián, Navarro, Marco-Antonio, Faulí, Adela, Ojeda, Antonio, Bogdanovich, Ana, Moreno, Luis-Alfonso, Hernández-Cera, Clara, Busquets, Carme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289547/ https://www.ncbi.nlm.nih.gov/pubmed/25580085 http://dx.doi.org/10.1186/1471-2253-14-120 |
Ejemplares similares
-
Capsaicin 8% Patch and Chronic Postsurgical Neuropathic Pain
por: Giaccari, Luca Gregorio, et al.
Publicado: (2021) -
Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
por: Kern, Kai-Uwe, et al.
Publicado: (2014) -
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain
por: Peppin, John F, et al.
Publicado: (2011) -
The Capsaicin 8% Patch for Neuropathic Pain in Clinical Practice: A Retrospective Analysis
por: Wagner, Till, et al.
Publicado: (2013) -
Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
por: Haanpää, M., et al.
Publicado: (2015)